November 01, 2025

Get In Touch

Biphasic Calcium Phosphate Tied To Higher Graft Volume Stability In Lateral Window Sinus Floor Elevation

Biphasic calcium phosphate tied to higher graft volume stability in lateral window sinus floor elevation suggests a new study published in the Clinical Oral Implants Research.
A study was done to assess in a prospective randomised trial two psychogenic bone substitutes—biphasic calcium phosphate (BCP) versus almost pure hydroxyapatite (HA)—for their volume stability and clinical implications after sinus floor elevation (SFE). Twenty patients requiring lateral-window sinus floor elevation 6 months before implant surgery were randomized to a biphasic calcium phosphate or hydroxyapatite group. As the primary outcome, the grafts were analyzed for volume stability, using four cone-beam computed tomography scans obtained immediately/6/12/24 months after sinus floor elevation. Secondary outcomes were implant survival, success, periotest values, oral-health-related quality of life (OHIP-G14), and pain (VAS).Results: Kolmogorov–Smirnov goodness-of-fit test revealed normal distribution of samples (p = .200). At 6/12/24 months, the augmented volumes decreased to 96/92/90% (HA) or 99/96/96% (biphasic calcium phosphate). Volume changes were significantly a factor of time and reached significantly lower values in the hydroxyapatite group. The significant intergroup difference in volume losses was notable at 24 months (p = .021; t-test for independent samples). Periotest values decreased from −3/−4.1 (HA/BCP) after implant placement to −6.3/−4.5 (HA/BCP) after 6 months. OHIP scores diverged at 2 months and largely resolved by 24 months. VAS scores were comparable, 2.2 at 1 week after sinus floor elevation being their highest mean level. After 2 years, both groups experienced no biological or technical complications, demonstrating a consistent healing trajectory without notable symptoms. Although no significant differences were observed in implant stability and survival, biphasic calcium phosphate demonstrated higher volume stability than hydroxyapatite.


Reference: Sokolowski, A., Theisen, K., Arefnia, B., Payer, M., Lorenzoni, M., & Sokolowski, A. (2023). A randomized clinical trial of phycogenic materials for sinus grafting with hydroxyapatite versus biphasic calcium phosphate: 2 years clinical outcomes. Clinical Oral Implants Research, 00, 1–12. https://doi.org/10.1111/clr.14209
Keywords: Biphasic calcium phosphate, graft volume, stability, lateral window, sinus floor elevation, Sokolowski, A., Theisen, K., Arefnia, B., Payer, M., Lorenzoni, M., & Sokolowski, A, Clinical Oral Implants Research

Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our Terms of Use, Privacy Policy, and Advertisement Policy.
For further details, please review our Full Disclaimer.

0 Comments

Post a comment

Please login to post a comment.

No comments yet. Be the first to comment!